| pubmed-article:16632240 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16632240 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:16632240 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
| pubmed-article:16632240 | lifeskim:mentions | umls-concept:C0115305 | lld:lifeskim |
| pubmed-article:16632240 | lifeskim:mentions | umls-concept:C0078056 | lld:lifeskim |
| pubmed-article:16632240 | lifeskim:mentions | umls-concept:C1749467 | lld:lifeskim |
| pubmed-article:16632240 | lifeskim:mentions | umls-concept:C0009566 | lld:lifeskim |
| pubmed-article:16632240 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:16632240 | lifeskim:mentions | umls-concept:C1553035 | lld:lifeskim |
| pubmed-article:16632240 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:16632240 | pubmed:dateCreated | 2006-4-24 | lld:pubmed |
| pubmed-article:16632240 | pubmed:abstractText | There are no large studies in Type 1 diabetic patients that have examined the relation between soluble adhesion molecules and micro- and macrovascular outcomes, although the risks of such complications are high. Therefore, the main objective is to examine the relationship between soluble (s) vascular cell adhesion molecule-1 (sVCAM-1) and sE-selectin and retinopathy, albuminuria, and cardiovascular disease (CVD) in Type 1 diabetic patients. | lld:pubmed |
| pubmed-article:16632240 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16632240 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16632240 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16632240 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16632240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16632240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16632240 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16632240 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16632240 | pubmed:issn | 1056-8727 | lld:pubmed |
| pubmed-article:16632240 | pubmed:author | pubmed-author:ChaturvediNis... | lld:pubmed |
| pubmed-article:16632240 | pubmed:author | pubmed-author:FullerJohn... | lld:pubmed |
| pubmed-article:16632240 | pubmed:author | pubmed-author:SchalkwijkCas... | lld:pubmed |
| pubmed-article:16632240 | pubmed:author | pubmed-author:StehouwerCoen... | lld:pubmed |
| pubmed-article:16632240 | pubmed:author | pubmed-author:EbelingPertti... | lld:pubmed |
| pubmed-article:16632240 | pubmed:author | pubmed-author:Soedamah-Muth... | lld:pubmed |
| pubmed-article:16632240 | pubmed:author | pubmed-author:EURODIAB... | lld:pubmed |
| pubmed-article:16632240 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16632240 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:16632240 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16632240 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16632240 | pubmed:pagination | 188-95 | lld:pubmed |
| pubmed-article:16632240 | pubmed:dateRevised | 2009-6-26 | lld:pubmed |
| pubmed-article:16632240 | pubmed:meshHeading | pubmed-meshheading:16632240... | lld:pubmed |
| pubmed-article:16632240 | pubmed:meshHeading | pubmed-meshheading:16632240... | lld:pubmed |
| pubmed-article:16632240 | pubmed:meshHeading | pubmed-meshheading:16632240... | lld:pubmed |
| pubmed-article:16632240 | pubmed:meshHeading | pubmed-meshheading:16632240... | lld:pubmed |
| pubmed-article:16632240 | pubmed:meshHeading | pubmed-meshheading:16632240... | lld:pubmed |
| pubmed-article:16632240 | pubmed:meshHeading | pubmed-meshheading:16632240... | lld:pubmed |
| pubmed-article:16632240 | pubmed:meshHeading | pubmed-meshheading:16632240... | lld:pubmed |
| pubmed-article:16632240 | pubmed:meshHeading | pubmed-meshheading:16632240... | lld:pubmed |
| pubmed-article:16632240 | pubmed:meshHeading | pubmed-meshheading:16632240... | lld:pubmed |
| pubmed-article:16632240 | pubmed:meshHeading | pubmed-meshheading:16632240... | lld:pubmed |
| pubmed-article:16632240 | pubmed:meshHeading | pubmed-meshheading:16632240... | lld:pubmed |
| pubmed-article:16632240 | pubmed:meshHeading | pubmed-meshheading:16632240... | lld:pubmed |
| pubmed-article:16632240 | pubmed:meshHeading | pubmed-meshheading:16632240... | lld:pubmed |
| pubmed-article:16632240 | pubmed:meshHeading | pubmed-meshheading:16632240... | lld:pubmed |
| pubmed-article:16632240 | pubmed:meshHeading | pubmed-meshheading:16632240... | lld:pubmed |
| pubmed-article:16632240 | pubmed:articleTitle | Soluble vascular cell adhesion molecule-1 and soluble E-selectin are associated with micro- and macrovascular complications in Type 1 diabetic patients. | lld:pubmed |
| pubmed-article:16632240 | pubmed:affiliation | Department of Epidemiology and Public-Health, Royal Free and University College London Medical School, London, UK, and Department of Internal Medicine, University Hospital Maastricht, The Netherlands. s.s.soedamah-muthu@umcutrecht.nl | lld:pubmed |
| pubmed-article:16632240 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16632240 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:16632240 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16632240 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16632240 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16632240 | lld:pubmed |
